MedPath

Feature Assessment Study for Indications Based Programming

Completed
Conditions
Ventricular Tachycardia
Ventricular Flutter
Ventricular Fibrillation
Heart Failure
Interventions
Device: Cognis 100-D, Teligen DR and VR 100 HE
Registration Number
NCT00711893
Lead Sponsor
Boston Scientific Corporation
Brief Summary

The purpose of this evaluation is to assess the acceptance level of specific programming recommendations based on the patient's clinical needs and primary indications when using the feature 'Indications Based Programming' (IBP) available in the ZOOMVIEW Software Application for the TELIGEN DR / VR and COGNIS family of devices compared to daily life programming chosen by physicians.

Detailed Description

"This study will focus on documenting the final parameter changes that are made in comparison to the IBP recommendations for a specific cardiovascular and arrhythmia history. It will therefore compare the device settings that were finally programmed during the last available follow up procedure to the last available parameter recommendations of IBP. IBP was designed to facilitate programming by providing customized parameter settings based on a patient's clinical needs and primary indication.

In order to further enhance the IBP feature for future device generations, additional data may be collected and evaluated on:

* Physician perception and satisfaction with the New User Interface (NUI) of the programming application;

* Motivation for adapting IBP recommendations for the final programming of the device;

* Device data that can be retrieved from patient data disks that may include but is not limited to, arrhythmia episode detail, pacing counter data; total and individual therapy data"

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
301
Inclusion Criteria
  • indicated for implantation of an ICD or CRT-D device according local hospital implant criteria guidelines

    • Implanted or intended to be implanted with any CE-marked device approved for implant from the TELIGEN (single or dual chamber ICD) or COGNIS (CRT-D) family during first implant (no replacements)
    • Geographically stable patients who are available for follow-up at a study centre
    • Age 18 or above, or of legal age to give informed consent specific to national law
Exclusion Criteria

Inability or refusal to sign the Patient Informed Consent

  • Pregnant or planning to become pregnant
  • Replacement device
  • Enrolment in another clinical trial, study or evaluation
  • Estimated life expectancy of less than six months per discretion of physician

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ICD and CRT-DCognis 100-D, Teligen DR and VR 100 HEPatients indicated for an implantable defibrillator or cardiac resynchronization defibrillator
Primary Outcome Measures
NameTimeMethod
Proportion of patients that are programmed by the physician to anything other than the recommended IBP setting6 Months
Secondary Outcome Measures
NameTimeMethod
- Degree of acceptance of IBP - Proportion parameters changed per patient - Differences between recommended and final programmed parameters - Total number of parameter changes from IBP recommendations - Frequency of changes made to a single parameter6 Months

Trial Locations

Locations (28)

Prince of Wales Hospital

πŸ‡¨πŸ‡³

Hong Kong, Hong Kong, China

Hartcentrum Hasselt - Dienst Cardiologie

πŸ‡§πŸ‡ͺ

Hasselt, Belgium

CHU Dijon - Hospital du Bocage

πŸ‡«πŸ‡·

Dijon, France

CMC Parly II

πŸ‡«πŸ‡·

Parly, France

Kerckhoff-Klinik GmbH

πŸ‡©πŸ‡ͺ

Bad Nauheim, Germany

Praxis Dres. Bischoff/Lang

πŸ‡©πŸ‡ͺ

Erfurt, Germany

Marienhospital Herne

πŸ‡©πŸ‡ͺ

Herne, Germany

Klinikum Kassel

πŸ‡©πŸ‡ͺ

Kassel, Germany

Praxis Schnabel der Praxisgemeinschaft Kardiologie Meissen

πŸ‡©πŸ‡ͺ

Meissen, Germany

Klinikum Dorothea Christiane Erxleben Quedlinburg GmbH

πŸ‡©πŸ‡ͺ

Quedlinburg, Germany

Paul Stradina Clinical University Hospital

πŸ‡±πŸ‡»

Riga, Latvia

University Hospital of Heraklion

πŸ‡¬πŸ‡·

Heraklion, Greece

Ziekenhius Rijnstate Arnhem

πŸ‡³πŸ‡±

Arnhem, Netherlands

Narodny ustav srdcvych a cievnych chorob

πŸ‡ΈπŸ‡°

Bratislava, Slovakia

Amphia Ziekenhius Breda

πŸ‡³πŸ‡±

Breda, Netherlands

Hospital Son Llatzer

πŸ‡ͺπŸ‡Έ

Palma de Mallorca, Spain

Hospital Universitario Central de Asturias

πŸ‡ͺπŸ‡Έ

Oviedo, Spain

Clinico Universitario de Valladolid

πŸ‡ͺπŸ‡Έ

Valladolid, Spain

University Hospital of Geneva

πŸ‡¨πŸ‡­

Geneva, Switzerland

CHU de Tours

πŸ‡«πŸ‡·

Tours Cedex, France

EHRU de Brest - Hospital de la Cavale Blanche

πŸ‡«πŸ‡·

Brest, France

Klinikum Nuernberg

πŸ‡©πŸ‡ͺ

Nuernberg, Germany

CHR OrlΓ©ans - Hospital la Source

πŸ‡«πŸ‡·

OrlΓ©ans, France

CHU de St. Etienne-Hospital Nord

πŸ‡«πŸ‡·

Saint Priest en Jarez, France

Centro Miguel Servet

πŸ‡ͺπŸ‡Έ

Zaragoza, Spain

Klinikum Fulda

πŸ‡©πŸ‡ͺ

Fulda, Germany

KH der Barmherzigen Schwestern Ried/Innkreis

πŸ‡¦πŸ‡Ή

Ried, Austria

KH der Elisabethinen Linz

πŸ‡¦πŸ‡Ή

Linz, Austria

Β© Copyright 2025. All Rights Reserved by MedPath